- · 《河南图书馆学刊》栏目[06/29]
- · 《河南图书馆学刊》数据[06/29]
- · 《河南图书馆学刊》投稿[06/29]
- · 《河南图书馆学刊》征稿[06/29]
- · 《河南图书馆学刊》刊物[06/29]
基因多态性与河南汉族人群非小细胞肺癌的关系(3)
作者:网站采编关键词:
摘要:[4] JIANG J, GENG G J, YU X Y, et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappa B/GLUT1 axis[J]. Oncotarget,2016
[4] JIANG J, GENG G J, YU X Y, et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappa B/GLUT1 axis[J]. Oncotarget,2016. 7(52):-.
[5] DO S K, JEONG J Y, LEE S Y, et al. Glucose transporter 1 gene variants predict the prognosis of patients with early stage nonsmall cell Lung cancer[J]. Ann Surg Oncol, 2018. 25(11):3396-3403.
[6] ABECASIS G R, ALTSHULER D, AUTON A, et al. A map of human genome variation from population-scale sequencing[J].Nature, 2010, 467(7319):1061-1073.
[7] ZHANG B, XIE Z D, LI B. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer:A meta-analysis[J]. Gene, 2019, 689:76-83.
[8] DU B, LIU S M, CUI C J, et al. Association between glucose transporter 1 rs polymorphism and type 2 diabetes mellitus risk may be population specific (1rs2)[J]. J Diabetes, 2013,5(3):291-299.
[9] Vaz-DRAGO R., CUSTODIO N M. Carmo-fonseca, deep intronic mutations and human disease[J]. Hum Genet, 2017, 136(9):1093-1111.
[10] MENDES de ALMEIDA R, TAVARES J, MARTINS S, et al. Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy[J]. PLoS One, 2017, 12(8):e0.
[11] SZAFRANSKI P, YANG Y, NELSON M U, et al. Novel FOXF1 deep intronic deletion causes lethal lung developmental disorder,alveolar capillary dysplasia with misalignment of pulmonary veins[J]. Hum Mutat, 2013, 34(11):1467-1471.
[12] OSADNIK T, STRZELCZYK J, BUJAK K, et al. Functional polymorphism rs in the gene coding GLUT1 protein is associated with in-stent restenosis[J]. Biomark Med, 2015, 9(8):743-750.
[13] BRAVATA V, STEFANO A, CAMMARATA F P, et al. Genotyping analysis and (1)(8)FDG uptake in breast cancer patients:a preliminary research[J]. J Exp Clin Cancer Res, 2013, 32:23.
[14] KIM S J, HWANG S H, KIM I J, et al. The association of18Fdeoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes(HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients[J]. J Exp Clin Cancer Res, 2010, 29:69.
[15] FENG W, CUI G, TANG C W, et al. Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer[J]. Oncotarget, 2017. 8(34):-.
[16] AMANN T, KIROVSKI G, BOSSERHOFF A K, et al. Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma[J]. Mol Membr Biol, 2011, 28(3):182-186.
文章来源:《河南图书馆学刊》 网址: http://www.hntsgxk.cn/qikandaodu/2021/0624/1639.html
上一篇:河南农村厕所革命梯度差异研究
下一篇:先秦青铜器纹饰的风格演变以河南出土文物为例